John Libbey Eurotext

European Journal of Dermatology

MENU

Peptidase inhibitor 3 and chemokine ligand 27 may serve as biomarkers for actinic keratoses in organ transplant recipients Volume 29, numéro 3, May-June 2019

Illustrations

  • Figure 1
  • Figure 2
  • Figure 3
  • Figure 4

Tableaux

Auteurs
1 Department of Dermatology, Medical University of Vienna,
2 Skin & Endothelial research division SERD, Department of Dermatology, University of Vienna,
3 Department of Dermatology, Federal Hospital of Wiener Neustadt,
4 Department of Dermatology, Research Division of Biology and Pathobiology of the Skin, Medical University of Vienna, Vienna, Austria
* Reprints
a These authors contributed equally
  • Mots-clés : actinic keratosis, skin markers, photodynamic therapy
  • DOI : 10.1684/ejd.2019.3559
  • Page(s) : 259-67
  • Année de parution : 2019

Background

Molecular profiling of tissue samples in organ transplant recipients (OTRs) may allow early and minimally invasive identification of actinic keratosis (AK).